FOCPX
Price
$20.29
Change
-$0.06 (-0.29%)
Updated
Sep 20 closing price
GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

FOCPX vs GFACX

Header iconFOCPX vs GFACX Comparison
Open Charts FOCPX vs GFACXBanner chart's image
Fidelity OTC
Price$20.29
Change-$0.06 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FOCPX vs GFACX Comparison Chart
Loading...
VS
FOCPX vs. GFACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCPX is a Buy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. FOCPX (30.7B). FOCPX pays higher dividends than GFACX: FOCPX (0.05) vs GFACX (0.00). FOCPX was incepted earlier than GFACX: FOCPX (40 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. FOCPX (15.00). FOCPX has a lower initial minimum investment than GFACX: FOCPX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 28.04 vs. FOCPX (19.29). FOCPX return over 5 years is better than : 71.89 vs. GFACX (45.21).
FOCPXGFACXFOCPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence40 years24 years-
Gain YTD8.52921.05541%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets30.7B290B11%
Annual Yield % from dividends0.050.00-
Returns for 1 year19.2928.0469%
Returns for 3 years1.08-3.58-30%
Returns for 5 years71.8945.21159%
Returns for 10 years148.2852.57282%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSSS3.870.02
+0.52%
SuRo Capital Corp
KRT25.94-0.01
-0.04%
Karat Packaging
PR13.86-0.02
-0.14%
Permian Resources Corp
TNDM42.64-0.42
-0.98%
Tandem Diabetes Care
RSLS0.16-0.01
-3.16%
ReShape Lifesciences